European Pharmaceutical Manufacturer magazine features Nemera’s article ‘A smarter approach’ about ophthalmic delivery for a better compliance.
The recently published European Pharmaceutical Manufacturer magazine includes the article from Nemera ‘Ophthalmic delivery: A smarter approach’, presenting how Nemera’s smart device e-Novelia® can improve patients’ lives.
In today’s healthcare world, there is an ever-increasing emphasis on patient’s adherence. The patient is now a priority because he is the one who will experience the device.
In the case of ophthalmic therapy, the quality and safety of eye drop use for patients treated in a healthcare setting play a vital role in the delivery of healthcare.
Underdosing or overdosing can lead to potential several problems.
That’s why at Nemera we’ve developed a multidose closing tip system preservative free and which limits the distribution of liquid to one drop at a time, with a precise and consistent drop size in order to improve patients’ adherence.
In response to the digitization of day to day life and considering the low patient adherence in ophthalmic treatments, we’ve developed an electronic add-on in order to assist patients in administrating their treatments. The e-Novelia add-on has been designed to add new functions to Novelia due to limitations of standard mechanical devices.
The full article:
The full issue of the magazine:
Nemera is a world leader in the design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology & generics industries.
Nemera always puts patients first, providing the most comprehensive range of devices in the industry, including off-the-shelf innovative systems, customized design development and contract manufacturing.